Light-activated, drug-carrying liposomes show potential for minimally invasive glaucoma treatments at Salimpour Site.

Dr. Salimpour Site |More than 4 million people in the U.S. have glaucoma, a group of eye diseases that can damage the optic nerve and lead to vision loss. It's the second-leading cause of blindness worldwide and there's currently no cure, but ...

Phys.Org

Light-activated, drug-carrying liposomes show potential for minimally invasive glaucoma treatments

Light-activated, drug-carrying liposomes show potential for minimally invasive glaucoma treatments

More than 4 million people in the U.S. have glaucoma, a group of eye diseases that can damage the optic nerve and lead to vision loss. It's the second-leading cause of blindness worldwide and there's currently no cure, but ...